NL-OMON29214尚未招募不适用
Vaccination with minor histocompatibility antigen-loaded donor DC vaccines to boost graft-versus-tumor immunity after allogeneic stem cell transplantation (a phase I study).
Radboud University Nijmegen Medical Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients positive for HLA-A2 and/or HLA-B7.
- •- Patients positive for HA-1, LRH-1 and/or ARHGDIB transplanted with the corresponding MiHA-negative donor.
排除标准
- •- Life expectancy < 3 months.
- •- Severe neurological or psychiatric disease.
研究者
相似试验
已完成
不适用
Vaccination with minor histocompatibility antigen-loaded donor DC vaccines to boost graft-versus-tumor immunity after allogeneic stem cell transplantation (a phase I study)blood cell cancerhematological malignancies10027656NL-OMON40014niversitair Medisch Centrum Sint Radboud10
进行中（未招募）
1 期
Dendritic cells vaccination after allogeneic stem cell transplantatioPatients with aggressive hematological malignancies treated with allogeneic stem cell transplantationEUCTR2012-002879-34-NLRadboud University Nijmegen Medical Centre
已完成
不适用
Vaccination with human minor H antigen (HA-1) peptide after allogeneic stem cell transplantatioISRCTN80896844eiden University Medical Centre (LUMC) (Netherlands)24
已完成
1 期
Predetermined Minor Histocompatibility Antigen-based Therapeutic or Prophylactic Peptide Vaccinations for Patients with Recurred Malignancies or Patients with High-Risk Malignancies Follwoing Allogeneic Hematopoietic Cell Transplantation.(1) Therapeutic vaccine: Any hematological malignancies recurred after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML, ALL, CML, Multiple Myeloma, NHL). (2) Prophylactic vaccine: Hematological malignancies with high risk of relapse after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML in >=3CR/non-CR or any AML with M0/M6/M7 FAB type, ALL in >=2CR/non-CR, CML in >=2CP or >=AP, Multiple Myeloma in PD, NHL in non-CR).JPRN-UMIN000000872Aichi Cancer Center Research Institute12
进行中（未招募）
不适用
Donor Dendritische Cellen vaccinatie bij hematologische maligne aandoeningeEUCTR2012-002435-28-NLniversity Medical Center Utrecht